Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Hotel and Hospitality AccorHotels to acquire 50% stake in US lifestyle hospitality company sbe Hotel industry news : AccorHotels, a French multinational hospitality company has proposed to acquire a stake of 50%… bySrinathJuly 1, 2018
